BRIEF-Valeant Pharma ups offering to $900 mln from $850 mln principal amount of notes
Nov 18 (Reuters) - Valeant Pharmaceuticals International Inc : * Says has priced its offering of 5.625% senior unsecured notes due 2021-SEC
filing * Valeant pharmaceuticals international inc -co increased the offering to $900
million from $850 million aggregate principal amount of notes * Source text () * Further company coverage
© Thomson Reuters 2017 All rights reserved.